A 2026 review finds that Staphylococcus aureus PBP4 may offer a dual target for reversing noncanonical antibiotic resistance ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible resultsSome results have been hidden because they may be inaccessible to you
Show inaccessible results